InMed Pharmaceuticals (INM) Other Working Capital Changes (2019 - 2026)
InMed Pharmaceuticals (INM) reported Other Working Capital Changes of -$42225.0 for Q1 2026, up 62.06% on a YoY basis from -$26055.0 in Q1 2025, and down 109.5% quarter-over-quarter from $444462.0 in Q4 2025.
InMed Pharmaceuticals (INM) Other Working Capital Changes (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals has reported Other Working Capital Changes for 8 years, with the latest figure at -$42225.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 62.06% year-over-year to -$42225.0; the trailing twelve-month figure through Mar 2026 stood at $180166.0 (up 489.94% YoY), and the FY2025 full-year result was -$429880.0, down 2019.31% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$42225.0, down from $444462.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $456731.0 in Q4 2022, with the low at -$442746.0 in Q2 2023.
- Historically, Other Working Capital Changes has averaged -$36894.0 across 5 years, with a median of -$101962.0 in 2024.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes plunged 208.35% — and 2025, when it jumped 556.24%.
- InMed Pharmaceuticals' Other Working Capital Changes stood at $456731.0 in 2022, then slumped by 80.31% to $89909.0 in 2023, then sank by 208.35% to -$97418.0 in 2024, then jumped by 556.24% to $444462.0 in 2025, then slumped by 109.5% to -$42225.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$42225.0 (Q1 2026), $444462.0 (Q4 2025), and -$107412.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | InMed Pharmaceuticals | 6.00 Mn | 756,271.05 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42,225.00 |
| Mar 31, 2026 | -42,225.00 |
| Dec 31, 2025 | 444,462.00 |
| Dec 31, 2025 | 444,462.00 |
| Sep 30, 2025 | -107,412.00 |
| Sep 30, 2025 | -107,412.00 |
| Jun 30, 2025 | -114,659.00 |
| Jun 30, 2025 | -114,659.00 |
| Mar 31, 2025 | -111,297.00 |
| Mar 31, 2025 | -111,297.00 |
| Dec 31, 2024 | -97,418.00 |
| Dec 31, 2024 | -97,418.00 |
| Sep 30, 2024 | -106,506.00 |
| Sep 30, 2024 | -106,506.00 |
| Jun 30, 2024 | 269,018.00 |
| Jun 30, 2024 | 269,018.00 |
| Mar 31, 2024 | -96,193.00 |
| Mar 31, 2024 | -96,193.00 |
| Dec 31, 2023 | 89,909.00 |
| Dec 31, 2023 | 89,909.00 |